Lung Transplantation for Covid-19–Related Respiratory Failure in the United States | NEJM
Correspondence from The New England Journal of Medicine — Lung Transplantation for Covid-19–Related Respiratory Failure in the United States
Related Articles
Empagliflozin after Acute Myocardial Infarction | NEJM
SGLT2 inhibitors improve cardiovascular outcomes in high-risk patients with diabetes, chronic kidney disease, or heart failure, but their effects after acute…
Drug-Induced Oxidative Hemolysis | NEJM
A 57-year-old woman presented with a 3-day history of shortness of breath and dizziness. Laboratory studies showed severe anemia with hemolysis, along with cellular abnormalities…
Interview with Kevin Schulman on unionization as a response to consolidation and corporatization in health care. | NEJM
Audio Interview from the New England Journal of Medicine — Interview with Kevin Schulman on unionization as a response to consolidation and corporatization in health…
The Quest for Transformative Tools to Eradicate Malaria | NEJM
We in the global malaria community are at a critical juncture in our journey toward malaria eradication. Decades of experience in deploying our existing interventions…
Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria | NEJM
Subcutaneous administration of the monoclonal antibody L9LS protected adults against controlled Plasmodium falciparum infection in a phase 1 trial. Whether a monoclonal antibody administered subcut…
Case 13-2024: A 27-Year-Old Man with Leg Weakness | NEJM
A 27-year-old man presented with weight loss, diarrhea, tremor, and proximal muscle weakness. The blood level of potassium was 1.8 mmol per liter. A diagnosis…
Exagamglogene Autotemcel for Severe Sickle Cell Disease | NEJM
Exagamglogene autotemcel (exa-cel) is a nonviral cell therapy designed to reactivate fetal hemoglobin synthesis by means of ex vivo clustered regularly interspaced short palindromic repeats…
Exagamglogene Autotemcel for Severe Sickle Cell Disease | NEJM
Exagamglogene autotemcel (exa-cel) is a nonviral cell therapy designed to reactivate fetal hemoglobin synthesis by means of ex vivo clustered regularly interspaced short palindromic repeats…
Buprenorphine Dispensing after Elimination of the Waiver Requirement | NEJM
In the year after the elimination of a waiver requirement to prescribe buprenorphine, the number of prescribers increased above the anticipated value, but the number…
Empagliflozin after Acute Myocardial Infarction | NEJM
Empagliflozin improves cardiovascular outcomes in patients with heart failure, patients with type 2 diabetes who are at high cardiovascular risk, and patients with chronic kidney…